CAS 202189-78-4
:Bilastine
Description:
Bilastine is a second-generation antihistamine primarily used for the treatment of allergic conditions such as allergic rhinitis and urticaria. It is characterized by its selective antagonism of peripheral H1 histamine receptors, which helps alleviate symptoms like itching, sneezing, and runny nose without causing significant sedation, a common side effect associated with first-generation antihistamines. Bilastine has a favorable pharmacokinetic profile, exhibiting rapid absorption and a long half-life, allowing for once-daily dosing. It is also noted for its minimal interaction with cytochrome P450 enzymes, reducing the risk of drug-drug interactions. The substance is typically administered orally and is well-tolerated, with a safety profile that supports its use in various populations, including children and the elderly. Overall, bilastine represents a modern approach to managing allergic symptoms with a focus on efficacy and safety.
Formula:C28H37N3O3
InChI:InChI=1S/C28H37N3O3/c1-4-34-20-19-31-25-8-6-5-7-24(25)29-26(31)22-14-17-30(18-15-22)16-13-21-9-11-23(12-10-21)28(2,3)27(32)33/h5-12,22H,4,13-20H2,1-3H3,(H,32,33)
InChI key:InChIKey=ACCMWZWAEFYUGZ-UHFFFAOYSA-N
SMILES:C(COCC)N1C(=NC=2C1=CC=CC2)C3CCN(CCC4=CC=C(C(C(O)=O)(C)C)C=C4)CC3
Synonyms:- 2-[-4-(2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl)phenyl]-2-methylpropanoic acid
- 2-[4-(2-{4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]piperidin-1-yl}ethyl)phenyl]-2-methylpropanoic acid
- 4-[2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethylbenzeneacetic acid
- Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-
- Bilastine
- Labixten
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-
CAS:Formula:C28H37N3O3Purity:98%Color and Shape:SolidMolecular weight:463.6117Ref: IN-DA002844
1g186.00€5g611.00€50gTo inquire100gTo inquire10mg55.00€50mg66.00€100mg73.00€250mg107.00€2-(4-(2-(4-(1-(2-EthoxyEthyl)-1H-Benzo[d]Imidazol-2-yl)Piperidin-1-yl)Ethyl)Phenyl)-2-mEthylpropanoic Acid
CAS:<p>2-(4-(2-(4-(1-(2-EthoxyEthyl)-1H-Benzo[d]Imidazol-2-yl)Piperidin-1-yl)Ethyl)Phenyl)-2-mEthylpropanoic Acid</p>Purity:99%Molecular weight:463.61g/molBilastine Impurity 5
CAS:Formula:C20H31N3O2Color and Shape:White To Off-White SolidMolecular weight:345.49Bilastine
CAS:Formula:C28H37N3O3Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:463.62Bilastine
CAS:<p>Bilastine (Bilaxten) is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of</p>Formula:C28H37N3O3Purity:99.86% - >99.99%Color and Shape:SolidMolecular weight:463.614-[2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-a,a-dimethylbenzeneacetic acid
CAS:<p>4-[2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-a,a-dimethylbenzeneacetic acid is a drug that belongs to the class of pharmacological agents. It is used to treat allergic symptoms and is intended for use in patients who are not responding to other therapies. This drug has been shown to be safe and effective in treating allergic rhinitis with or without conjunctivitis. The pharmacokinetics of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-a,a-dimethylbenzeneacetic acid are linear over the clinically relevant dose range and show no evidence of any significant interactions with other drugs. It has also been shown to have no effect on hepatic function or renal function in patients</p>Formula:C28H37N3O3Purity:Min. 95%Molecular weight:463.61 g/mol







